Respiratory Health Diagnostic Seeks New Partner As RB Deal Aborted
Executive Summary
Australia's ResApp has terminated a deal with RB to bring to market a smartphone app to identify different respiratory conditions. Previously, Sanofi and ResApp failed to agree a deal for the technology.